期刊
ACTA NEUROPATHOLOGICA
卷 118, 期 5, 页码 587-598出版社
SPRINGER
DOI: 10.1007/s00401-009-0597-x
关键词
Parkinson's disease; Alpha-synuclein; Lewy body; Neuropathology; Dementia; Cognitive dysfunction; Beta-amyloid; Tau
资金
- UK Parkinson's Disease Society [948776, G-0709]
- Parkinson's UK [G-0909] Funding Source: researchfish
Dementia in Parkinson's disease (PD/PDD) is a common complication with a prevalence of up to 50%, but the specific changes underlying the cognitive decline remain undefined. Neuronal degeneration resulting in the dysfunction of multiple subcortical neurochemical projection systems has been described along with Lewy body-type pathology in cortical and limbic regions. Advanced alpha-synuclein (alpha Syn) pathology is not necessarily sufficient for producing dementia and concomitant Alzheimer's disease (AD) change has also been proposed as a possible substrate of PDD. A lack of consensus in the extant literature likely stems from clinical heterogeneity and variable reliability in clinical characterisation as well as other historical and methodological issues. The concurrent presence of abnormally deposited alpha Syn, amyloid-beta and tau proteins in the PDD brain and the interaction of these molecules in a linked pathological cascade of AD and PD-related mechanisms may prove important in determining the underlying pathological process for the development of dementia in PD and this concept of combined pathologies awaits further investigation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据